Prophylactic Favipiravir for Healthcare Workers in COVID-19 Pandemic

Phase 3

Recruiting

• Conditions: covid-19.; covid19 disease; U07.1

• Registration Number: IRCT20150107020592N30
• Lead Sponsor: Vice chancellor for research, Shahid Beheshti university of medical sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 13 July 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

Age over 20 years
Nurses in the intensive care unit
Satisfaction with entering the plan

Exclusion Criteria

Sensitivity to antiviral drugs

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Infection with Covid 19. Timepoint: Three weeks after starting treatment. Method of measurement: Nasal swap prc covid-19.